Even as Germany's BioNTech deals with ongoing declines of its revenue and share price, it's facing another serious concern: U.S. officials are pressing the company to pay royalties linked to the ...
March 25 (Reuters) - BioNTech (22UAy.DE), opens new tab said on Monday the U.S. National Institutes of Health has sent a notice to the German company regarding default on the payment of royalties and ...
BioNTech SE shared its Q3 earnings, business updates, and guidance for 2025 earlier today. Its share price is down 1% in trading so far. BNTX maintains a strong cash position, driven by ongoing ...
BioNTech (BNTX) shares have shown mixed momentum over the past month, with a modest recovery in the past week. Investors seem to be weighing the company’s recent performance as they consider its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback